Literature DB >> 27569104

Erlotinib as first line treatment in a NSCLC patient with choroidal metastasis and with EGFR exon 19 deletion.

Hakan Kocoglu1, Mustafa Karaca, Rustu Turkay, Deniz Tural.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27569104

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer.

Authors:  Matthew G Field; H Culver Boldt; Taher Abu Hejleh; Elaine M Binkley
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.